NLS Pharmaceutics
NLSP
NLSP
5 hedge funds and large institutions have $102K invested in NLS Pharmaceutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$31K |
| 2 |
2
Renaissance Technologies
New York
|
$31K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$5K |
Top Sellers
| 1 |
1
Two Sigma Investments
New York
|
$0 |
| 2 |
2
Two Sigma Advisers
New York
|
$0 |
| 3 |
HF
3
HRT Financial
New York
|
$0 |
| 4 |
VF
4
Virtu Financial
New York
|
$0 |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$15K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $31K | +$15.6K | +273 | +101% |
|
|
2
Citadel Advisors
Miami,
Florida
| $31K | +$31K | +541 | New |
|
3
Geode Capital Management
Boston,
Massachusetts
| $20K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $15K | -$3.06K | -54 | -17% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $5K | +$5K | +92 | New |
|
|
6
Two Sigma Investments
New York
| – | -$51K | -1,147 | Closed |
|
|
7
Two Sigma Advisers
New York
| – | -$25K | -570 | Closed |
|
|
HF
8
HRT Financial
New York
| – | -$15K | -351 | Closed |
|
|
VF
9
Virtu Financial
New York
| – | -$12K | -265 | Closed |
|